n3 PUFAs do not affect adipose tissue inflammation in overweight to moderately obese men and women

Journal of Nutrition

Volumn 143, Issue 8, 2013, Pages 1340-1347

  Kratz, Mario ^a,c   Kuzma, Jessica ^a   Hagman, Derek ^a,c   Yserloo, Brian van ^d   Matthys, Colleen ^e   Callahan, Holly ^e   Weigle, Davids ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b Division of Metabolism Endocrinology and Nutrition   (United States)

^c Department of Epidemiology ^*  (United States)

^d Dept of Obstetrics and Gynecology   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OMEGA 3 FATTY ACID; PLACEBO; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOSE TISSUE; ADIPOSE TISSUE INFLAMMATION; ADULT; ARTICLE; BODY MASS; CALORIC INTAKE; CONTROLLED STUDY; DIET RESTRICTION; DIET THERAPY; DIETARY INTAKE; DISEASE SEVERITY; DRUG MEGADOSE; FEEDING; FEMALE; GENE EXPRESSION; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MALE; NORMAL HUMAN; OBESITY; OUTCOME ASSESSMENT; PLANT; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT CHANGE;

ADIPOSE TISSUE; ADULT; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; DIET; ENERGY INTAKE; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INFLAMMATION; INSULIN; LINEAR MODELS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; SINGLE-BLIND METHOD; TRIGLYCERIDES; YOUNG ADULT;

EID: 84881356298     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.113.174383     Document Type: Article

References (33)

1. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. Recent advances in the relationship between obesity, inflammation,and insulin resistance. Eur Cytokine Netw. 2006;17:4-12.
2. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132:2169-80.
3. Chapkin RS, Kim W, Lupton JR, McMurray DN. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation.Prostaglandins Leukot Essent Fatty Acids. 2009;81:187-91.
4. Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients.2010;2:355-74.
5. Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH, Hong S, Serhan CN. Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol. 2005;174:4345-55.
6. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010;142:687-98.
7. Todoric J, Loffler M, Huber J, Bilban M, Reimers M, Kadl A, Zeyda M, Waldhausl W, Stulnig TM. Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia. 2006;49:2109-19.
8. Kalupahana NS, Claycombe K, Newman SJ, Stewart T, Siriwardhana N, Matthan N, Lichtenstein AH, Moustaid-Moussa N. Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat dietinduced obese mice via modulation of adipose tissue inflammation. J Nutr. 2010;140:1915-22.
9. Saraswathi V, Gao L, Morrow JD, Chait A, Niswender KD, Hasty AH.Fish oil increases cholesterol storage in white adipose tissue with concomitant decreases in inflammation, hepatic steatosis, and atherosclerosis in mice. J Nutr. 2007;137:1776-82.
10. Itariu BK, Zeyda M, Hochbrugger EE, Neuhofer A, Prager G, Schindler K, Bohdjalian A, Mascher D, Vangala S, Schranz M, et al. Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. Am J Clin Nutr. 2012;96:1137-49.
11. Kabir M, Skurnik G, Naour N, Pechtner V, Meugnier E, Rome S,Quignard-Boulange A, Vidal H, Slama G, Clement K, et al. Treatment for 2 mo with n-3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr. 2007;86:1670-9.
12. Kratz M, Callahan HS, Yang PY, Matthys CC, Weigle DS. Dietary n-3-polyunsaturated fatty acids and energy balance in overweight or moderately obese men and women: a randomized controlled trial.Nutr Metab (Lond). 2009;6:24.
13. Kratz M, Swarbrick MM, Callahan HS, Matthys CC, Havel PJ, Weigle DS. Effect of dietary n-3 polyunsaturated fatty acids on plasma total and high-molecular-weight adiponectin concentrations in overweight to moderately obese men and women. Am J Clin Nutr. 2008;87:347-53.
14. Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr. 1990;51:241-7.
15. Campbell KL, Makar KW, Kratz M, Foster-Schubert KE, McTiernan A,Ulrich CM. A pilot study of sampling subcutaneous adipose tissue to examine biomarkers of cancer risk. Cancer Prev Res (Phila). 2009;2:37-42.
16. Mac Micking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol. 1997;15:323-50.
17. Ekström M, Liska J, Eriksson P, Sverremark-Ekstrom E, Tornvall P.Stimulated in vivo synthesis of plasminogen activator inhibitor-1 in human adipose tissue. Thromb Haemost. 2012;108:485-92.
18. Juhan-Vague I, Alessi MC, Mavri A, Morange PE. Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J Thromb Haemost. 2003;1:1575-9.
19. Cirino G, Fiorucci S, Sessa WC. Endothelial nitric oxide synthase: the Cinderella of inflammation? Trends Pharmacol Sci. 2003;24:91-5.
20. Han CY, Subramanian S, Chan CK, Omer M, Chiba T, Wight TN,Chait A. Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and Resadhesion. Diabetes. 2007;56:2260-73.
21. Cataĺan V, Gomez-Ambrosi J, Rotellar F, Silva C, Rodriguez A,Salvador J, Gil MJ, Cienfuegos JA, Fruhbeck G. Validation of endogenous control genes in human adipose tissue: relevance to obesity and obesity-associated type 2 diabetes mellitus. Horm Metab Res. 2007;39:495-500.
22. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:research0034.1-.11.
23. Rangel-huerta OD, Aguilera CM, Mesa MD, Gil A. Omega-3 longchain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. Br J Nutr.2012;107 suppl 2:S159-70.
24. Ill ́an-Ǵomez F, Gonzalvez-Ortega M, Orea-Soler I, Alcaraz-Tafalla MS,Aragon-Alonso A, Pascual-Diaz M, Perez-Paredes M, Lozano-almela ML. Obesity and inflammation: change in adiponectin, C-reactive protein,tumour necrosis factor-alpha and interleukin-6 after bariatric surgery.Obes Surg. 2012;22:950-5.
25. Appachi S, Kelly KR, Schauer PR, Kirwan JP, Hazen S, Gupta M,Kashyap SR. Reduced cardiovascular risk following bariatric surgeries is related to a partial recovery from "adiposopathy". Obes Surg. 2011;21:1928-36.
26. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL,Chen CL, Tai TY, Chuang LM.Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001;86:3815-9.
27. Imayama I, Ulrich CM, Alfano CM, Wang C, Xiao L, Wener MH,Campbell KL, Duggan C, Foster-schubert KE, Kong A, et al. Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res. 2012;72:2314-26.
28. Zhao Y, He X, Shi X, Huang C, Liu J, Zhou S, Heng CK. Association between serum amyloid A and obesity: a meta-analysis and systematic review. Inflamm Res. 2010;59:323-34.
29. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ,Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia.2003;46:459-69.
30. Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, Wang F, Hull RL, Boyko EJ, Retzlaff BM, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes. 2002;51: 1005-15.
31. Nieves DJ, Cnop M, Retzlaff B, Walden CE, Brunzell JD, Knopp RH,Kahn SE. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat.Diabetes. 2003;52:172-9.
32. Klimćakov́a E, Roussel B, Marquez-quinones A, Kovacova Z,Kovacikova M, Combes M, Siklova-vitkova M, Hejnova J, Sramkova P, Bouloumie A, et al.Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response.J Clin Endocrinol Metab. 2011;96:E73-82.
33. Klimcakova E, Roussel B, Kovacova Z, Kovacikova M, Siklova-Vitkova M, Combes M, Hejnova J, Decaunes P, Maoret JJ, Vedral T,et al. Macrophage gene expression is related to obesity and the metabolic syndrome in human subcutaneous fat as well as in visceral fat.Diabetologia. 2011;54:876-87.